Trial intelligence / Profile preview

Triesence in glaucoma surgery

NCT00853905Phase 3Completed

Sponsor
Wills Eye Hospital
Start
Feb 2009
Primary completion
Dec 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of triamcinolone acetonide in Glaucoma, sponsored by Wills Eye Hospital. Started Feb 2009; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT00853905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00853905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call